Literature DB >> 19747991

Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head.

Yong Feng1, Shu-Hua Yang, Bao-Jun Xiao, Wei-Hua Xu, Shu-Nan Ye, Tian Xia, Dong Zheng, Xian-Zhe Liu, Yun-Fei Liao.   

Abstract

INTRODUCTION: Once non-traumatic avascular necrosis of the femoral head (ANFH) happened, vascular impairment and feeble collateral circulation are followed by poor outcomes. Circulating endothelial progenitor cells (EPCs) may substantially contribute to vascular homeostasis such as vascular repair and new blood vessel growth. We investigated whether abnormalities in EPCs levels and functions are present in ANFH patients.
METHODS: 54 ANFH patients were enrolled, including steroid-induced (n=21), alcohol-induced (n=15) and idiopathic ANFH (n=18), and 30 healthy subjects as control (HC). The numbers of circulation EPCs were determined by fluorescence-activated cell-sorting (FACS) analysis. EPCs cultured from peripheral blood mononuclear cells on fibronectin to induce the expression of receptors for acetylated low-density lipoprotein and ulex-lectin. EPCs colony-forming units (CFUs) were observed from 54 patients and 30 healthy controls. Migratory capacity to chemo-attractants (vascular endothelial growth factor) cellular senescence levels and in vitro angiogenesis ability were assessed in age-matched subjects (n=10 per groups).
RESULTS: Mean numbers of circulating EPC were 1460+/-265 cells/ml in HC, 545+/-177 in ANFH, (P<0.001). Mean numbers of CFUs were 26.2+/-6.2 in HC, 19.6+/-7.7 in ANFH,(P<0.001). Although there were not significant differences in circulating EPC and CFUs among the steroid-induced, alcohol-induced or idiopathic three groups, all these risk factors contributed to the decreased circulating EPCs numbers and CFUs. In addition, EPCs from ANFH patients showed reduced migratory capacity and increased cellular senescence compared with EPCs from normal subjects, furthermore the ability of angiogenesis in vitro was also impaired.
CONCLUSION: Circulating endothelial progenitor cells (EPCs) numbers and functions are reduced in ANFH patients, suggesting that risk factors of ANFH may alter EPCs biology in angiogenesis and vascular repair. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19747991     DOI: 10.1016/j.bone.2009.09.001

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  41 in total

1.  The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study.

Authors:  Qiang Mao; Hongting Jin; Fei Liao; Luwei Xiao; Di Chen; Peijian Tong
Journal:  Bone       Date:  2013-08-29       Impact factor: 4.398

Review 2.  Clinical effect of hyperbaric oxygen therapy in the treatment of femoral head necrosis : A systematic review and meta-analysis.

Authors:  Wei Li; Ziliang Ye; Wei Wang; Kun Wang; Lang Li; Dewei Zhao
Journal:  Orthopade       Date:  2017-05       Impact factor: 1.087

Review 3.  Cytotherapy of osteonecrosis of the femoral head: a mini review.

Authors:  You-Shui Gao; Chang-Qing Zhang
Journal:  Int Orthop       Date:  2010-04-02       Impact factor: 3.075

4.  Combination treatment of biomechanical support and targeted intra-arterial infusion of peripheral blood stem cells mobilized by granulocyte-colony stimulating factor for the osteonecrosis of the femoral head: a randomized controlled clinical trial.

Authors:  Qiang Mao; Weidong Wang; Taotao Xu; Shanxing Zhang; Luwei Xiao; Di Chen; Hongting Jin; Peijian Tong
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

Review 5.  Biology of Bone: The Vasculature of the Skeletal System.

Authors:  Emma C Watson; Ralf H Adams
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

6.  Real-time computerised tomography assisted porous tantalum implant in ARCO stage I-II non-traumatic osteonecrosis of the femoral head: minimum five-year follow up.

Authors:  Ruyin Hu; Pengfei Lei; Bo Li; Hao Liu; Xucheng Yang; Ting Wen; Yihe Hu; Xiaobin Tian
Journal:  Int Orthop       Date:  2018-03-27       Impact factor: 3.075

Review 7.  Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challenge.

Authors:  Michaela Kuhlen; Marina Kunstreich; Kathinka Krull; Roland Meisel; Arndt Borkhardt
Journal:  Blood Adv       Date:  2017-06-13

Review 8.  Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.

Authors:  Christian Powell; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

Review 9.  Stem Cell Therapy for Osteonecrosis of the Femoral Head: Current Trends and Comprehensive Review.

Authors:  Lei Zhao; Alan David Kaye; Aaron J Kaye; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

10.  Knee loading protects against osteonecrosis of the femoral head by enhancing vessel remodeling and bone healing.

Authors:  Daquan Liu; Xinle Li; Jie Li; Jing Yang; Hiroki Yokota; Ping Zhang
Journal:  Bone       Date:  2015-09-28       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.